
20 August 2020
All local recommended safety guidelines followed at the time of interview.
The team at Mako Medical recognizes senior living communities face unique challenges and are especially vulnerable to disease outbreaks. Syndromic testing is used at this lab to ensure fast results, knowing that delays can present a real dilemma for patients living in close quarters.
icon-cta-blockquote2
We've seen many things that come through senior care populations whether because there are immunity suppressed or whether they're on antibiotics.
Steve Hoover, President of lab operations, Mako Medical
icon-cta-blockquote2
We believe in syndromic testing because we don’t have to spend a lot of time diagnosing a patient who might not have a lot of time to get that diagnosis.
Steve Hoover, President of lab operations, Mako Medical
icon-cta-blockquote2
Our value to our patients and to our provider community has increased by bringing the QIAstat-Dx in-house.
Joshua Arant, Founder and Chief Operations Officer, Mako Medical
Do you want accurate and timely clinical insights for your patients?
Learn more about QIAstat-Dx
Other stories
-
Analyzing the ancient origins of rare genetic diseasesEsteemed geneticist, Dr. Bisgin, uses QIAGEN bioinformatic tools to help find a cure for rare genetic diseases in Turkey.
-
Battling tuberculosis in the time of COVID-19Dr. Story brings tuberculosis testing and treatment to susceptible homeless communities knowing that a disruption in TB testing during COVID would have major consequences.
-
Tuberculosis diagnosis turns patients into advocatesOver a decade ago, the Halsteads returned from their honeymoon with an infection known to kill 1.5 million people a year globally and learned how to overcome the disease.
*Product availability may differ from country to country based on regulations and approvals. Contact your country representative for further details.